This inventor holds 1 USPTO granted patent. Top assignee: British Technology Group Limited. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Wieslaw M Cholody: Innovator in Antineoplastic Compounds
Introduction
Wieslaw M Cholody is a notable inventor based in Wejherowo, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antineoplastic agents. His work focuses on innovative compounds that have the potential to impact cancer treatment.
Latest Patents
Wieslaw M Cholody holds a patent for "Antineoplastic modified imidazoacridines," which includes compounds of formula I. This patent highlights the structural variations of the compounds, where R represents either --OH or --OR', with R' being a C1-C6 alkyl group. This innovation is crucial in the ongoing search for effective cancer therapies.
Career Highlights
Cholody is associated with British Technology Group Limited, where he applies his expertise in developing new pharmaceutical compounds. His work has been instrumental in advancing the understanding of imidazoacridine derivatives and their applications in oncology.
Collaborations
Wieslaw M Cholody has collaborated with Jerzy Kazimierz Konopa, contributing to the research and development of novel therapeutic agents. Their partnership has fostered innovation in the field of cancer treatment.
Conclusion
Wieslaw M Cholody's contributions to the field of antineoplastic compounds exemplify the importance of innovation in medicine. His work continues to inspire advancements in cancer therapies, showcasing the potential of modified imidazoacridines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile